Tandem Diabetes Care has announced the integration of its software for its new, updated t: slim X2 insulin pump with the latest G7 Continuous Glucose Monitor made by Dexcom in the United States. That’s a big deal since Tandem Insulin is the first to integrate its hybrid closed-loop system with the advanced Dexcom G7 CGM. In this blog, we will discuss on update tandem pump to Dexcom G7.
What makes the Dexcom G7 stand out?
The Dexcom G7, newly FDA-approved, is a game changer for continuous glucose monitoring. A notable fact about it is that it shrinks by 60% compared to the predecessor, G6, making it much smaller and thus more inconspicuous in wear with improved comfort for the user. The G7 also comes with a warm-up time of 30 minutes; moreover, there is a 12-hour grace period for switching sensors without interference.
By integrating the G7 and the t: slim X2 pump, users can now experience greater convenience, precision, and more extended periods spent in the Control-IQ mode.
Getting Acquainted with Control-IQ Technology
This is a Control-IQ technology- an advanced hybrid closed-loop insulin delivery system that utilizes predictive algorithms to optimize insulin delivery. It can forecast glucose levels up to 30 minutes in advance and adjust insulin delivery every five minutes. It can even give an automatic correction bolus once in an hour. Thus, the technology dramatically aids individuals with diabetes in increasing their time in range-a critical element of managing the condition.
Free upgrade to Tandem pump customers
Tandem insulin pump aims at helping people living with diabetes, which is precisely why the company intends to make this advanced technology available free of charge as a complimentary and remote software update fully to over 300000 current t: slim X2 customers in the United States. New customers will have it already pre-loaded with the updated software, which shows Tandem Pump’s interest in advancing AID systems.
As correctly said, “The integration of the Dexcom G7 and t: slim X2 insulin pump is the culmination of years of collaboration and a mutual commitment to enhancing lives of people with diabetes,” by Jake Leach, Executive Vice President and COO at Dexcom.
Advantages of this Integration
To the user, this kind of integration comes with considerable advantages:
- No-fingerstick: The Dexcom G7 is the first to offer a no-fingerstick experience from the get-go, thus making glucose monitoring easy.
- Speed and Accuracy: Dubbed the fastest and most accurate CGM, the G7 delivers timely and reliable data.
- Predictive Alerts: Features such as the Urgent Low Soon alert warn users of impending low glucose levels up to 20 minutes ahead, allowing them to manage the situation proactively.
- Capabilities of Share: Users can share their glucose readings with up to 10 people so that people around the user increase their knowledge and care for them.
Tandem t: slim X2 Insulin pump. Expected benefits to include:
- Time in Range: Patients who use Dexcom are in range over 2.6 hours/day
- Auto Correction Bolus: The system offers an auto-correction bolus of up to one per hour to maximize proper insulin delivery.
- Customizable settings: Up to six Personal Profiles, configurable to each user’s distinct insulin needs;
- Mobile bolus: Bolus from your phone with the t: connect mobile app, empowering you to take control of your diabetes on the go;
Integrating Dexcom G7 continuous glucose monitoring with Tandem Diabetes Care’s insulin pumps represents the new standard for accuracy, ensuring reliable delivery of insulin.
Conclusion
The union of the Dexcom G7 and Tandem t: slim X2 pump will revolutionize diabetes management in ways that users have never felt before, say nothing of bettering the patient’s control over their condition. Tandem insulin pumps will bring this technology to more countries outside the U.S. early in 2024, a significant leap forward in worldwide diabetes care. The partnership of Dexcom with the Tandem insulin pump symbolizes a substantial step in diabetes management, bringing ease and manageability to life for people suffering from this condition. With these new and innovative products, one can look forward to a future with better care and much healthier outcomes.